PDF(Pubmed)
Abstract：
Neuroendocrine neoplasms (NENs) are a diverse group of tumors with varying clinical behaviors. Their incidence has risen due to increased awareness, improved diagnostics, and aging populations. The 2019 World Health Organization classification emphasizes integrating radiology and histopathology to characterize NENs and create personalized treatment plans. Imaging methods like CT, MRI, and PET/CT are crucial for detection, staging, treatment planning, and monitoring, but each of them poses different interpretative challenges and none are immune to pitfalls. Treatment options include surgery, targeted therapies, and chemotherapy, based on the tumor type, stage, and patient-specific factors. This review aims to provide insights into the latest developments and challenges in NEN imaging, diagnosis, and management.
摘要：
神经内分泌肿瘤（NENs）是一组具有不同临床行为的肿瘤。由于意识的增强，他们的发病率上升了，改进的诊断,和人口老龄化。2019年世界卫生组织分类强调整合放射学和组织病理学以表征NEN并创建个性化治疗计划。像CT这样的成像方法,MRI,PET/CT对检测至关重要，分期,治疗计划,和监测,但是他们每个人都提出了不同的解释性挑战，没有一个能幸免于陷阱。治疗方案包括手术,靶向治疗,和化疗，根据肿瘤类型，舞台,和患者特定因素。这篇综述旨在提供有关NEN成像的最新发展和挑战的见解，诊断,和管理。
